<--- Back to Details
First PageDocument Content

AquaBounty Technologies, Inc. (“AquaBounty” or “the Company”) FDA Approves AquAdvantage® Salmon MAYNARD, Massachusetts, 19 November 2015 – AquaBounty Technologies, Inc. (AIM: ABTU; OTC: AQBT), a biotechnology

Add to Reading List

Source URL: www.aquabounty.com

Download Document from Source Website

File Size: 85,32 KB

Share Document on Facebook

Similar Documents